The infamous ‘Pharma Bro’, Martin Shkreli, will remain in jail until his hearing after he issued a $5000 bounty for a strand of Hilary Clinton’s hair.
The former pharmaceuticals CEO will stay in jail until his sentencing for three accounts of fraud.
Judge Kiyo A. Matsumoto gave the ruling this week stating he felt ‘compelled’ to side with the government and deny Shkreli an opportunity to post bail.
The judge claimed his inappropriate Facebook post – which offered money for a piece of Clinton’s hair – posed a serious ‘danger’, something Shkreli and his attorneys claimed was harmless satire.
However, according to The Independent, the prosecution wrote:
There is a significant risk that one of his many social media followers or others who learn of his offers through the media will take his statements seriously.
Shkreli did issue an apologetic letter to the court, saying he was sorry for the ‘poor judgement’ and it wasn’t his intention to ’cause alarm or promote any act of violence’.
In a separate letter to the court his attorney Benjamin Brafman reasoned:
His constitutionally-protected political hyperbole does not rise to the level of making a ‘danger to the community.’
Unfortunately for Shkreli and his legal team, their pleas fell on deaf ears as Judge Matsumoto said his social media post was a ‘solicitation of an assault’ not protected by the First Amendment, saying he felt there would a real risk in someone taking Shkerli’s offer seriously.
Martin Shkerli’s notoriety began in September 2015 when he raised the price for the AIDS drug Daraprim.
It’s price went up from from $13.50 (£10.23) to $750 (£568) per pill and this unpopular move made him ‘the most hated man in America’, thus giving birth to the term ‘Pharma Bro’.
He caused even more ire, this time among the hip-hop community, when he used his vast funds to purchase the one and only copy of Once Upon A Time In Shaolin by iconic rap group, Wu-Tang Clan.
As reported by TMZ, he even sent a video threat to Ghostface Killah, (Dennis Coles), after he criticised him for his questionable business practices.
On December 2015, Shkreli was arrested by the FBI following a federal indictment charge for securities fraud and following his arrest, he stepped down as CEO of Turing Pharmaceuticals.